Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis.

@article{Hogewind2008IntravitrealTF,
  title={Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis.},
  author={Barend F.T. Hogewind and Carla Zijlstra and B. Jeroen Klevering and Carel B. Hoyng},
  journal={European journal of ophthalmology},
  year={2008},
  volume={18 3},
  pages={429-34}
}
PURPOSE Cystoid macular edema (CME) is the most significant cause of visual loss associated with idiopathic uveitis. The authors report on the use of intravitreal triamcinolone acetonide (IVTA) in a group of patients with macular edema due to idiopathic intermediate and posterior uveitis. METHODS Retrospective, noncomparative, interventional case series. Thirty-three eyes were included with uveitic CME that was refractory to topical steroids, oral prednisone, or a combination thereof… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…